Royal Marsden researchers named among world’s most influential scientists

Six researchers at The Royal Marsden NHS Foundation Trust and our partner academic institution, The Institute of Cancer Research, London (ICR), have been named in a list of the world's most influential and innovative researchers over the last decade.

From left to right (top) row: Professors de Bono, Cunningham and Harrington. Bottom row: Professors Larkin, Turner and Emeritus Professor Dowsett.

From left to right, top row: Professors Johann de Bono, David Cunningham and Kevin Harrington. Bottom row: Professors James Larkin, Nicholas Turner and Emeritus Professor Mitch Dowsett.

Professors David Cunningham, James Larkin, Nicholas Turner, Johann de Bono, Kevin Harrington, and Emeritus Professor Mitch Dowsett feature in the latest Highly Cited Researchers list published by science analytics company Clarivate. The number of times an academic paper is cited in the papers published by other researchers' is a measure of recognition by peers their influence within their research field.

The list, which uses the number of highly-cited papers that rank in the top 1% by citations for field and year over the last decade, identifies those who are world leading.

Professor David Cunningham, Director of Clinical Research at The Royal Marsden and Director of the NIHR Biomedical Research Centre at The Royal Marsden and the ICR, has conducted late phase clinical trials that have significantly improved the survival and outcome for patients, especially with gastrointestinal cancers.

Professor James Larkin is a Consultant Medical Oncologist at The Royal Marsden and Professor in the Division of Clinical Studies at the ICR. He specialises in the treatment of melanoma and cancers of the kidney and is developing personalised treatments for patients with cancer and using new targeted treatments that boost the immune system's ability to fight cancer.

Professor Nicholas Turner is a Consultant Medical Oncologist at The Royal Marsden where he is also Head of the Ralph Lauren Centre for Breast Cancer Research. He leads the Molecular Oncology Team at the ICR and is Chief Investigator of numerous clinical trials on personalised therapies for breast cancer.

Emeritus Professor Mitch Dowsett was Head of the joint Academic Department of Biochemistry at The Royal Marsden and the ICR and studies the role of hormones in breast cancer. He has been a pioneer in the clinical development of aromatase inhibitors in breast cancer treatment.

Professor Johann de Bono is Head of the Oak Foundation Drug Development Unit at The Royal Marsden and the ICR. He is Regius Professor of Cancer Research and a Professor in Experimental Cancer Medicine at the ICR, where he is a prostate cancer expert and a leading figure in his field. He leads major international prostate cancer trials and has a research programme underpinning them.

Professor Kevin Harrington is a Consultant Oncologist at The Royal Marsden and Professor of Biological Cancer Therapies at the ICR. He is a world-leading expert in the development of immunotherapy in cancer treatments, specialising in developing new treatments using biologically targeted agents like viruses, antibodies and small molecules that selectively destroy cancer cells.

Highly cited researchers are identified in the Clarivate list for their exceptional research performance, determined by the publication of multiple papers that rank in the top 1% by citations for their field over 10 years.

Professors Dowsett, Harrington and Turner were also listed in the 'Cross-Field' category, which recognises researchers who have been influential across several fields in the last 10 years.